Creating neoantigens by design… …to transform cancer treatments into cures

Aethon Therapeutics engineers novel antibodies, customized to be used in combination with targeted therapies to selectively kill drug-resistant cancer cells.

Aethon’s HapImmune™ platform: The convergence of targeted and immune therapy